DE

477.85

+1.78%↑

FDX

241.56

-0.91%↓

CPRT

57.2

+1.13%↑

HEICO

269.51

+0.96%↑

HEICA

212.51

+0.9%↑

DE

477.85

+1.78%↑

FDX

241.56

-0.91%↓

CPRT

57.2

+1.13%↑

HEICO

269.51

+0.96%↑

HEICA

212.51

+0.9%↑

DE

477.85

+1.78%↑

FDX

241.56

-0.91%↓

CPRT

57.2

+1.13%↑

HEICO

269.51

+0.96%↑

HEICA

212.51

+0.9%↑

DE

477.85

+1.78%↑

FDX

241.56

-0.91%↓

CPRT

57.2

+1.13%↑

HEICO

269.51

+0.96%↑

HEICA

212.51

+0.9%↑

DE

477.85

+1.78%↑

FDX

241.56

-0.91%↓

CPRT

57.2

+1.13%↑

HEICO

269.51

+0.96%↑

HEICA

212.51

+0.9%↑

Search

Enovis Corp

Suletud

SektorTööstus

37.17 -2.24

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

36.7

Max

38.14

Põhinäitajad

By Trading Economics

Sissetulek

-672M

-703M

Müük

56M

561M

Aktsiakasum

0.98

Kasumimarginaal

-125.353

Töötajad

7,367

EBITDA

-602M

-590M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+64.12% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

1. mai 2025

Turustatistika

By TradingEconomics

Turukapital

-445M

2.2B

Eelmine avamishind

39.41

Eelmine sulgemishind

37.17

Uudiste sentiment

By Acuity

50%

50%

207 / 468 Pingereas Industrials

Enovis Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

7. jaan 2025, 23:28 UTC

Suurimad hinnamuutused turgudel

Maplebear Up on S&P MidCap 400 Inclusion

Võrdlus sarnastega

Hinnamuutus

Enovis Corp Prognoos

Hinnasiht

By TipRanks

64.12% tõus

12 kuu keskmine prognoos

Keskmine 62.71 USD  64.12%

Kõrge 75 USD

Madal 46 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Enovis Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

8 ratings

7

Osta

1

Hoia

0

Müü

Sentiment

By Acuity

207 / 468 Pingereas Tööstus

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Keskmine

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Enovis Corp

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.